MannKind Corp - Company Profile
Powered by 
All the sales intelligence you need on MannKind Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how MannKind Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with MannKind Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
MannKind Corp (Mannkind) focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. The company harnesses its patented Technosphere formulation technology, lead product Afrezza, and improved financial performance. However, limited market penetration could be a setback for the company. Nevertheless, the company could find opportunities from the global diabetes care device market, strategic agreement, and acquisition of scPharmaceuticals. However, intense competition, economic and geopolitical uncertainties, and government regulations could impact the company’s operational and financial performance.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer